Stress Management and Biological Age in Breast Cancer Patients.RCT

Sponsor
Maria Charalampopoulou (Other)
Overall Status
Recruiting
CT.gov ID
NCT05984914
Collaborator
Hippocration General Hospital (Other), Saint Savvas Anticancer Hospital (Other), Hellenic Anticancer Institute (Other)
60
1
2
35.9
1.7

Study Details

Study Description

Brief Summary

Intense stress has harmful effects on the body, contributing to various disorders. Breast cancer patients experience a build-up of stress due to their diagnosis and treatments. Stress can cause epigenetic changes in a cellular level (such as accelerated increase in biological age) that may negatively affect oncological treatments.

This study aims to investigate the effect of stress management, specifically the Pythagorean Self-Awareness Intervention, on telomere length in T-leukocytes of breast cancer patients after completing all treatments except hormonal therapy. The study involves self-referred questionnaires, hair cortisol collection, and blood material extraction.

Understanding the role of stress management in breast cancer may lead to improved patient outcomes and survival rates.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: PSAI
  • Behavioral: One day seminar
N/A

Detailed Description

Distress can have serious effects on the human body and is known to contribute to various disorders, including cardiovascular diseases. In the case of breast cancer, patients often experience a build-up of stressful events throughout their journey with the disease, such as diagnosis, surgery, chemotherapy, radiotherapy, survival, and dealing with side effects of anticancer therapy.

Many studies have shown that psychological stress is closely related to increased cortisol levels in the body. This stress may lead to epigenetic changes in telomere length, the action of telomerase, the function of T-leukocytes, and the response of pro-inflammatory cytokines, all of which play significant roles in the treatment of oncological patients.

Considering these factors, managing stress becomes crucial, as it can not only indirectly affect the disease's outcome but also impact survival. This scientific protocol aims to investigate the impact of a holistic stress management program on the telomere length of T-leukocytes in the peripheral blood of women diagnosed with breast cancer.

The stress management technique to be employed is the Pythagorean Self-Awareness Intervention, which will be administered only after completing all cancer treatments, except for hormonal therapy. The methods that will be followed include distributing self-referred questionnaires to assess stress and lifestyle, collecting hair cortisol samples, and extracting genetic (DNA) material to study the telomere length of T-cells from peripheral blood.

By studying the impact of stress and its management on telomere length in breast cancer patients, this study aims to contribute to a better understanding of how stress affects health outcomes and potentially provide insights into improving patient care.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Psychological and Biological Outcomes in Breast Cancer Patients After Pythagorean Self-Awareness Intervention.
Actual Study Start Date :
Jan 4, 2021
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: PSAI group

Participants are enrolled in the Pythagorean Self-Awareness Intervention (PSAI) where they receive weekly group sessions of 120 min for 8 weeks and they receive information about stress and lifestyle modifications and they are also instructed to practice the PSAI at bedtime and in the morning, every day, at home.

Behavioral: PSAI
The 8 sessions included biofeedback training in diaphragmatic breathing, information about distress, its symptoms, ways to manage stress through lifestyle modifications (physical activity, principals of Mediterranean diet without alcohol consumption, sleep hygiene, diaphragmatic breathing, conflict avoidance) & instructions for lymphedema prevention, introduction to the Pythagorean Self-Awareness Intervention, instructions for the implementation of the technique, analysis of the Golden Verses,and their connection with lifestyle medicine as well as active involvement of the participants with group conversation and sharing of experiences.
Other Names:
  • Pythagorean Self-Awareness Intervention
  • Active Comparator: Control group

    One day seminar where they receive information about stress and lifestyle modifications

    Behavioral: One day seminar
    The one day seminar included biofeedback training in diaphragmatic breathing, information about distress, its symptoms, ways to manage stress through lifestyle modifications (physical activity, principals of Mediterranean diet without alcohol consumption, sleep hygiene, diaphragmatic breathing, conflict avoidance) & instructions for lymphedema prevention.

    Outcome Measures

    Primary Outcome Measures

    1. Psychological I [9 weeks after the 1st session]

      Perceived stress (measured by Perceived Stress Scale-14, expected decrease in mean score)

    2. Psychological II [9 weeks after the 1st session]

      Symptoms of anxiety-stress-depression (measured by Depression Anxiety Stress Scale-21, expected decrease in mean scores)

    3. Physical I [9 weeks after the 1st session]

      Telomere length (measured in mean T/S)

    4. Physical II [9 weeks after the 1st session]

      Hair cortisol levels (measured in pg/mg )

    Secondary Outcome Measures

    1. Physical III [9 weeks after the 1st session]

      Body Composition Analysis (measured in kg and %)

    2. Psychological III [9 weeks after the 1st session]

      QOL (measured by European Organization for Research and Treatment Questionnaire, expected increase in means score)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Diagnosis of primary breast cancer

    • Completion of anticancer therapy (except for hormonal therapy)

    Exclusion Criteria:
    • Psychiatric diagnosis and treatment

    • Metastasis

    • Previous participation in any stress management and health promotion study

    • Inability to read or write in Greek

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Agios Savvas Hospital Athens Greece 11522

    Sponsors and Collaborators

    • Maria Charalampopoulou
    • Hippocration General Hospital
    • Saint Savvas Anticancer Hospital
    • Hellenic Anticancer Institute

    Investigators

    • Study Director: Flora Bacopoulou, MD,PhD, Aghia Sofia Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Maria Charalampopoulou, PhD candidate, National and Kapodistrian University of Athens
    ClinicalTrials.gov Identifier:
    NCT05984914
    Other Study ID Numbers:
    • 2513
    First Posted:
    Aug 9, 2023
    Last Update Posted:
    Aug 9, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Maria Charalampopoulou, PhD candidate, National and Kapodistrian University of Athens
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 9, 2023